MMW — System, Test, Tumor Marker, Monitoring, Bladder Class II
FDA product code MMW covers "System, Test, Tumor Marker, Monitoring, Bladder", a Class II medical device regulated under 21 CFR 866.6010. Submissions are reviewed by the Immunology panel. At least 9 recent 510(k) clearances have been granted under this product code.
Classification details
- Product Code
- MMW
- Device Class
- Class II
- Regulation Number
- 866.6010
- Submission Type
- 510(k)
- Review Panel
- IM
- Medical Specialty
- Immunology
- Implant
- No
Recent 510(k) clearances
| K-Number | Applicant | Device Name | Date |
|---|---|---|---|
| K203245 | Nucleix | Bladder EpiCheck DNA extraction kit, NX899090-01C, Bladder EpiCheck test kit… | May 4, 2023 |
| K033982 | Vysis | MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST | Jan 22, 2004 |
| K021231 | Matritech | NMP22 BLADDERCHEK KIT, NMP22 CONTROL KIT | Jul 30, 2002 |
| K013785 | Vysis | UROVYSION BLADDER CANCER RECURRENCE KIT | Feb 8, 2002 |
| K011031 | Vysis | VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT | Aug 3, 2001 |
| K974845 | Bard Diagnostic Sciences | BTA STAT TEST PRESCRIPTION HOME USE | Dec 8, 1998 |
| K971402 | Bard Diagnostic Sciences | BARD BTA TRAK TEST | Apr 15, 1998 |
| K970353 | Perimmune | AURA TEK FDP | Apr 30, 1997 |
| K964151 | Bard Diagnostic Sciences | BARD AND BTA TEST | Apr 16, 1997 |